Assignee
SUN PHARMA GLOBAL FZE
AE·9 granted patents·7 pending applications·22 citations·filing 2005–2021
Top patents by PatentIndex Score
16 records- 0191US10918694B2Topical cyclosporine-containing formulations and uses thereofSUN PHARMA GLOBAL FZE·Filed 2017·Granted Feb 16, 2021·11 cites·4 claims
- 0287US10292990B2Abiraterone steroid formulationSUN PHARMA GLOBAL FZE·Filed 2016·Granted May 21, 2019·4 cites·2 claims
- 0378US7790935B2Process for preparation of citalopram and enantiomersSUN PHARMA GLOBAL FZE·Filed 2005·Granted Sep 7, 2010·3 cites·7 claims
- 0477US7964742B2Process for preparation of citalopram and enantiomersSUN PHARMA GLOBAL FZE·Filed 2010·Granted Jun 21, 2011·3 cites·6 claims
- 0573US11154560B2Methods for treating ocular inflammatory diseasesSUN PHARMA GLOBAL FZE·Filed 2019·Granted Oct 26, 2021·1 cites·9 claims
- 0668US2021145924A1Topical cyclosporine-containing formulations and uses thereofSUN PHARMA GLOBAL FZE·Filed 2021·Application pending·0 cites
- 0767US10980818B2Methods for treating ocular inflammatory diseasesSUN PHARMA GLOBAL FZE·Filed 2018·Granted Apr 20, 2021·0 cites·16 claims
- 0861US2020009137A1Topical formulations and uses thereofSUN PHARMA GLOBAL FZE·Filed 2019·Application pending·0 cites
- 0961US2021205330A1Methods for treating ocular inflammatory diseasesSUN PHARMA GLOBAL FZE·Filed 2021·Application pending·0 cites
- 1059US2019008874A1Abiraterone Acetate Formulation and Methods of UseSUN PHARMA GLOBAL FZE·Filed 2018·Application pending·0 cites
- 1158US7989645B2Process for preparation of citalopram and enantiomersSUN PHARMA GLOBAL FZE·Filed 2008·Granted Aug 2, 2011·0 cites·3 claims
- 1249US2019231885A1Topical formulations and uses thereofSUN PHARMA GLOBAL FZE·Filed 2016·Application pending·0 cites
- 1347US2011251410A1Process for preparation of citalopram and enantiomersSUN PHARMA GLOBAL FZE·Filed 2011·Application pending·0 cites
- 1443US9943520B2Oral formulation and suspension of an oncology drugSUN PHARMA GLOBAL FZE·Filed 2014·Granted Apr 17, 2018·0 cites·6 claims
- 1539US10426781B2Oral formulation and suspension of an oncology drugSUN PHARMA GLOBAL FZE·Filed 2017·Granted Oct 1, 2019·0 cites·26 claims
- 1637US2018333352A1Topical formulations and uses thereofSUN PHARMA GLOBAL FZE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SUN PHARMA GLOBAL FZE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →